KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 139 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $92,374 | -92.7% | 106,470 | -84.9% | 0.00% | -100.0% |
| Q2 2023 | $1,258,481 | -29.3% | 703,062 | +34.2% | 0.01% | -50.0% |
| Q4 2022 | $1,780,879 | +62.5% | 523,788 | +115.6% | 0.01% | +25.0% |
| Q2 2022 | $1,096,000 | -28.9% | 242,997 | +65.9% | 0.01% | -66.7% |
| Q1 2021 | $1,541,000 | +9.0% | 146,442 | +60.3% | 0.02% | +20.0% |
| Q4 2020 | $1,414,000 | +198.9% | 91,338 | +181.6% | 0.02% | +185.7% |
| Q3 2020 | $473,000 | – | 32,431 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,827,078 | $82,205,000 | 4.43% |
| Palo Alto Investors LP | 4,663,324 | $79,416,000 | 3.21% |
| Private Capital Advisors, Inc. | 473,901 | $8,071,000 | 2.23% |
| DOHENY ASSET MANAGEMENT /CA | 215,445 | $3,669,000 | 1.92% |
| Sandia Holdings, LLC | 119,739 | $2,039,000 | 0.96% |
| Capital Impact Advisors, LLC | 102,006 | $1,744,000 | 0.60% |
| Birchview Capital, LP | 50,000 | $852,000 | 0.55% |
| EMERALD ADVISERS, LLC | 694,068 | $11,820,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 647,307 | $11,024,000 | 0.37% |
| Schonfeld Strategic Advisors LLC | 418,100 | $7,121,000 | 0.32% |